Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.11
+0.23 (1.45%)
At close: Oct 24, 2025, 4:00 PM EDT
16.12
+0.01 (0.06%)
After-hours: Oct 24, 2025, 5:23 PM EDT
IART Stock Forecast
Stock Price Forecast
The 5 analysts that cover IART stock have a consensus rating of "Hold" and an average price target of $15.4, which forecasts a -4.41% decrease in the stock price over the next year. The lowest target is $12 and the highest is $25.
Price Target: $15.4 (-4.41%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 3 | 3 | 3 | 3 | 3 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | -6.89% | Oct 15, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $10 → $12 | Strong Sell | Maintains | $10 → $12 | -25.51% | Oct 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $35 → $25 | Buy | Maintains | $35 → $25 | +55.18% | May 9, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $24 → $12 | Sell | Maintains | $24 → $12 | -25.51% | May 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $25 → $13 | Hold | Maintains | $25 → $13 | -19.30% | May 6, 2025 |
Financial Forecast
Revenue This Year
1.70B
from 1.61B
Increased by 5.74%
Revenue Next Year
1.78B
from 1.70B
Increased by 4.35%
EPS This Year
2.26
from -0.09
EPS Next Year
2.47
from 2.26
Increased by 9.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.8B | 1.8B | |
| Avg | 1.7B | 1.8B | |
| Low | 1.6B | 1.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.3% | 7.9% | |
| Avg | 5.7% | 4.3% | |
| Low | 1.1% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.37 | 2.76 | |
| Avg | 2.26 | 2.47 | |
| Low | 2.15 | 2.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 22.4% | |
| Avg | - | 9.3% | |
| Low | - | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.